Candriam SCA’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-186,102
| Closed | -$26.6M | – | 664 |
|
|
2023
Q2 | $26.6M | Sell |
186,102
-117,924
| -39% | -$17.4M | 0.19% | 132 |
|
|
2023
Q1 | $38.8M | Buy |
304,026
+4,754
| +2% | +$640K | 0.27% | 90 |
|
|
2022
Q4 | $40.6M | Sell |
299,272
-5,742
| -2% | -$720K | 0.27% | 86 |
|
|
2022
Q3 | $33.5M | Sell |
305,014
-17,052
| -5% | -$2.16M | 0.24% | 98 |
|
|
2022
Q2 | $42.6M | Sell |
322,066
-116,864
| -27% | -$15.3M | 0.35% | 68 |
|
|
2022
Q1 | $58.2M | Sell |
438,930
-91,675
| -17% | -$11M | 0.4% | 61 |
|
|
2021
Q4 | $61.8M | Buy |
530,605
+16,388
| +3% | +$1.93M | 0.39% | 58 |
|
|
2021
Q3 | $61.8M | Buy |
514,217
+385,524
| +300% | +$44.9M | 0.42% | 54 |
|
|
2021
Q2 | $15.4M | Buy |
128,693
+46,901
| +57% | +$5.15M | 0.11% | 225 |
|
|
2021
Q1 | $7.86M | Buy |
81,792
+58
| +0.1% | +$5.83K | 0.07% | 294 |
|
|
2020
Q4 | $8.17M | Buy |
81,734
+22,181
| +37% | +$2.35M | 0.06% | 302 |
|
|
2020
Q3 | $6.53M | Buy |
59,553
+32,210
| +118% | +$3.58M | 0.06% | 312 |
|
|
2020
Q2 | $2.89M | Sell |
27,343
-22,697
| -45% | -$2.34M | 0.03% | 428 |
|
|
2020
Q1 | $4.88M | Buy |
50,040
+32
| +0.1% | +$3.01K | 0.05% | 353 |
|
|
2019
Q4 | $4.99M | Buy |
+50,008
| New | +$4.71M | 0.05% | 360 |
|
|
2018
Q1 | – | Sell |
-10,600
| Closed | -$736K | – | 765 |
|
|
2017
Q4 | $736K | Sell |
10,600
-6,838
| -39% | -$461K | 0.01% | 629 |
|
|
2017
Q3 | $1.18M | Sell |
17,438
-402
| -2% | -$25.4K | 0.02% | 544 |
|
|
2017
Q2 | $1.22M | Hold |
17,840
| – | – | 0.02% | 547 |
|
|
2017
Q1 | $1.11M | Hold |
17,840
| – | – | 0.02% | 548 |
|
|
2016
Q4 | $975K | Hold |
17,840
| – | – | 0.02% | 520 |
|
|
2016
Q3 | $1.17M | Sell |
17,840
-2,160
| -11% | -$141K | 0.03% | 465 |
|
|
2016
Q2 | $1.21M | Buy |
+20,000
| New | +$1.16M | 0.03% | 398 |
|
Other funds holding AZN
